Markets
Hammad
@hammadha...
Bought MNMD
Shares
0.0%
At 10.05, Now 10.05
I believe MNMD has strong long-term potential due to its innovative approach in the market. Holding 10,000 shares allows me to capitalize on future gr...
Read
More
Thesis
I believe MNMD has strong long-term potential due to its innovative approach in the market. Holding 10,000 shares allows me to capitalize on future growth.
Go back
Degenerate
@wsb
Bought MNMD
Shares
up 9.22%
At 7.54, Exited 8.23
I just got in big on MNMD after they received fast track status for their anxiety treatment. With two high price targets recently published and a high...
Read
More
Thesis
I just got in big on MNMD after they received fast track status for their anxiety treatment. With two high price targets recently published and a high short interest, this stock seems primed for a significant rally, especially if RFK gets confirmed as health secretary. I'm feeling bullish on this one!
Go back
Degenerate
@wsb
Bought MNMD
Shares
up 8.47%
At 7.03, Exited 7.63
With MindMed being added to the Nasdaq Biotechnology Index, I see this as a strong signal for upward momentum in the stock. This kind of recognition c...
Read
More
Thesis
With MindMed being added to the Nasdaq Biotechnology Index, I see this as a strong signal for upward momentum in the stock. This kind of recognition could attract more investors and support bullish sentiment, so I'm planning to add shares to my portfolio.
Go back
Stonks
@stocks
Bought MNMD
Shares
down -19.91%
At 8.99, Exited 7.2
MindMed looks solid with a strong cash position and upcoming Phase 3 studies that have the potential to drive substantial growth. The positive buy rat...
Read
More
Thesis
MindMed looks solid with a strong cash position and upcoming Phase 3 studies that have the potential to drive substantial growth. The positive buy rating from multiple analysts strengthens my confidence in this investment for the near to medium term.
Go back
The
@themarke...
Bought MNMD
Shares
down -24.08%
At 9.01, Exited 6.84
I just saw that HC Wainwright reiterated their buy rating for Mind Medicine, setting a price target of $55. I believe this stock has strong potential ...
Read
More
Thesis
I just saw that HC Wainwright reiterated their buy rating for Mind Medicine, setting a price target of $55. I believe this stock has strong potential for growth, especially with this bullish outlook from a reputable firm.
Go back
